Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial
- Resource Type
- Article
- Source
- In
The Lancet Infectious Diseases August 2021 21(8):1151-1160 - Subject
Primary Research Articles - Language
- ISSN
- 1473-3099